Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of two inhaled fluticasone propionate + salmeterol formulations
PACTR201507001200173Phase 0Completed
- Sponsor
- Prosonix
- Start
- Aug 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 0 trial of fluticasone propionate and salmeterol in asthma (2 arms), sponsored by Prosonix. Primary endpoints: Plasma fluticasone propionate levels and Plasma salmeterol xinafoate levels. Started Aug 2015; status: completed.
02
Drugs
fluticasone propionatesalmeterol
03
Conditions
asthma
Beyond the preview
Go deeper on PACTR201507001200173.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201507001200173.